AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
CARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) -- This article contains affiliate links. If you purchase through these links, a commission…
Schindellegi, Switzerland – 23 December 2025 Trifork Group AGCompany announcement no. 60/2025European Regulatory News Reporting of transactions made by persons…
San Francisco, CA, Dec. 23, 2025 (GLOBE NEWSWIRE) -- PULSESUN Trading Center has completed a series of infrastructure and system-level…
GAMIVO's analyses indicates that 60% of gamers prefer games released between 2021 and 2025. December 23, 2025 11:40 ET |…
PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec.…
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…
Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved…
ROSWELL, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- DataGavel, the LegalTech platform built to give defendants a faster, data-driven edge…
December 22, 2025 14:05 ET | Source: Mawson Infrastructure Group Inc. MIDLAND, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mawson…